Clinical Trial Update: Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction at Altitude [Phase 1]

View source ↗

Summary

Phase 1 trial investigating iloprost for hypoxic pulmonary vasoconstriction at altitude has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic Pulmonary Vasoconstriction

Drugs mentioned

• Ventavis (iloprost)

Snippet

Sponsor: Loma Linda University | Conditions: Hypoxic Pulmonary Vasoconstriction | Phase 1 | Status: WITHDRAWN